Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 3,149 |
| Other current assets | 93 |
| TOTAL | $3,242 |
| Non-Current Assets | |
| PPE Net | 97 |
| Other Non-Current Assets | 3 |
| TOTAL | $100 |
| Total Assets | $3,271 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 116 |
| Other current liabilities | 85 |
| TOTAL | $201 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $201 |
| Shareholders' Equity | |
| Retained earnings | -6,446 |
| Other shareholders' equity | 9,348 |
| TOTAL | $3,070 |
| Total Liabilities And Equity | $3,271 |